HomeNewsIndiaIn-Depth | Aarogya Setu app: From efficacy to privacy concerns, what’s under the hood of Centre’s COVID-19 contact tracing app

In-Depth | Aarogya Setu app: From efficacy to privacy concerns, what’s under the hood of Centre’s COVID-19 contact tracing app

The app is people dependent, which means it needs widespread usage and regular self-reporting to be effective. Given the fact that there are bound to be variations in the levels of self-reporting, the efficacy of the app is apparently not foolproof.

May 15, 2020 / 21:33 IST
Story continues below Advertisement

In the fight against COVID-19, the government of India has launched a mobile contact tracing application called Aarogya Setu to help people assess their risk of getting infected with the novel coronavirus and alert authorities if they have come in close contact with an infected person.

Developed by the National Informatics Centre (NIC) under the Ministry of Electronics and Information Technology (MeitY) and launched on April 2, the app got a big push when Prime Minister Narendra Modi urged the nation to download it, saying it is an important step in the country's fight against COVID-19.

Story continues below Advertisement

Within two weeks of its launch, the app became the fastest app to reach 50 million downloads. It has crossed 10 crore registrations in just 41 days.

The app has alerted around 1.4 lakh users in the country about a possible risk of infection due to proximity to infected persons and helped generate information about 697 potential hotspots in the country, said a report published on May 12.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show